Syndeio Biosciences, Inc

This study tests whether a new oral drug called zelquistinel can reduce depression symptoms in adults with major depressive disorder. Participants take one tablet weekly for 6 weeks and have their depression severity checked at each clinic visit. The trial compares the drug again…

This study tests a new oral drug called zelquistinel to see if it can reduce symptoms of major depressive disorder in adults. About 164 people aged 18 to 64 will take either the drug or a placebo once a week for 6 weeks. Researchers will measure changes in depression severity usi…